|
|
|
We will due diligent China partnership selection process, using our well established China clients’ base and strategic connections; we will identify and evaluate potential R&D partners, partners for co-development licensing agreements, potential partners for technology transfer and strategic alliances. We can also facilitate the process of a potential acquisition negotiation to help large Chinese biopharmaceutical companies to forge strong alliance with UK and European R&D companies. We will identify and evaluate potential alliance partners and undertake due diligence in respect of acquisitions.
• technology focus:
> Technologies that can be commercialized into large markets, which are dominated by few committed companies
> Technologies which can be introduced as ancillary products into existing physician sales call points
> Markets that are not highly fragmented
> Early stage design or prototypes
> Uncomplicated capitalization structure
> Strong intellectual property
• Partnerships, JV's, Mergers and Acquisitions
• Licence
|
